Keystone Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Keystone Financial Planning's BMY Position: Q3 2026 in Review
Keystone Financial Planning reduced its Bristol-Myers Squibb (BMY) stake by 1% in Q3 2026, selling an estimated $101K and leaving 155,174 shares worth $9.7M. The position accounts for 2.4% of the portfolio, ranked #11.
Keystone Financial Planning first reported a position in BMY in Q4 2013 and has held it in 19 quarters since. The position peaked at $9.7M in Q1 2025. 1,266 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Keystone Financial Planning held 155,174 shares of Bristol-Myers Squibb worth $9.7M as of Q3 2026.
- Keystone Financial Planning sold 1,594 Bristol-Myers Squibb shares in Q3 2026, an estimated $101K.
- Bristol-Myers Squibb made up 2.4% of Keystone Financial Planning's portfolio in Q3 2026, its #11 holding.
- Keystone Financial Planning first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 19 quarters since.
- Keystone Financial Planning's Bristol-Myers Squibb position peaked at $9.7M in Q1 2025.
- 1,266 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Keystone Financial Planning's 13F filing for Q3 2026, filed 8 Oct 2026.